Shopping Cart (0)
My Account

Your Shopping Cart
Academic Discovery WorkshopAdvances in Plant Genomics - Online EventTranslational Regenerative Medicine Congress 2014ISEV2014 Educational EventBiofluid Biopsies and Companion Diagnostics 201420% Discount OfferePoster Award PrizeBlogs

Algae Biofuel: Why Not Now?

Publisher: Emerging Tech Insights, Inc.
Published: September 2011
Pages: 87

Price:



A Strategic Technology Assessment

Algae biofuel is either just around the corner or off in the distant future.  Which?  We used a patented technology mapping process from Emerging Tech Insights, Inc. to answer the question and to Get Beyond the Hype® in algae biofuels. 

Based on our analysis, algae biofuel or biodiesel does appear to be poised to disrupt the liquid fuel business.  Commercial sales are quietly beginning in “specialty” markets.  Our analysis of the technology landscape shows that there are few technological barriers.  For most process steps, well characterized methods can be drawn from a parallel industry.  Only large-scale culture systems need further “standardization” to enable a large-scale algae biofuel industry to break out, and even here a limited number of well-defined options already exist.

Our analysis clearly shows the adjacent markets that can serve as outlets for algae biofuel “waste” products, reducing scrap costs.  Adjacent markets can also serve to finance biofuel market development.

When an algae biofuel industry breaks out, we believe that existing smaller players will begin to consolidate and our cutting-edge models suggest combinations of companies where intellectual property enhancements might exist. 

When a large scale algae biofuel industry does break out, we also believe that winners will include the equipment and chemical suppliers for “standardized” ponds and bioreactors, new aqua culture farmers, suppliers of extraction equipment and chemicals, certain real estate holders and the investors and managers who made it all happen.

If you are considering investment in the algae biofuel area, this report will help you decide where to invest your R&D effort or where an acquisition or partnership might be the best approach.  It will give you an inside look at existing competitors and where they are investing today and what they may have already abandoned. 

You don’t need to take our word for it.  With this report, you also gain access to the unique technology landscape model from which the conclusions were drawn.

Report Table of Contents (TOC) [Click Here to Download PDF File]


For enquiries about this market report, please contact Kathy Gray at Kathy.Gray@Selectbiosciences.com

Conference News
Papers Presented in the Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference can be Published in CSBJ
Papers Presented in the Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference can be Published in CSBJ
Computational and Structural Biotechnology Journal [CSBJ (ISSN 2001-0370)] will devote a conference special issue comprising of selected articles from the speakers/oral and poster presenters of Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference. Selected authors will receive an invitation to submit full length manuscripts to CSBJ. The full length manuscripts will undergo the peer-review process as per CSBJ policies. From July-2014, CSBJ will be part of ELSEVIER Open-access


LAB-ON-A-CHIP ASIA - EARLY BIRD
LAB-ON-A-CHIP ASIA - EARLY BIRD
SAVE UP TO S$150 - EARLY BIRD DEADLINE 10 OCTOBER 2014. Don't miss out - register today!


Site Visit to the SIMTech Microfluidics Foundry
Site Visit to the SIMTech Microfluidics Foundry
Take advantage of a tour of the facilities at the SIMTech Microfluidic Foundry. Dr. Zhiping Wang, Director of Research Programmes, will be your host, providing all attendees with a detailed insight into the advanced work carried out by SIMTech. Don't miss out - Register today!


Keynote Speaker Confirmed, Stephen Minger
We are thrilled to announce that Stephen Minger, Global Director of GE Healthcare, has confirmed he will be giving a keynote presentation at Stem Cells in Drug Discovery 2015.


Call for papers - Clinical Applications of Stem Cells 2015
Call for papers - Clinical Applications of Stem Cells 2015
We are now accepting papers for the Clinical Applications of Stem Cells meeting which will take place on the 26-27 of February 2015 in Singapore.


Keynote Speakers Confirmed, Carlos Caldas and Mark Caulfield
We are thrilled to announce that Professor Carlos Caldas, Group Leader at the Cancer Research UK Cambridge Institute and Professor Mark Caufield, Chief Scientist of the Genomics England 100,000 project, have both confirmed their keynote presentations at Personalized Medicine in May 2015, Cambridge.

Scroll Up
Scroll Down
Keep me updated Select Bio Blog LinkedIn Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com